Advancing Discovery Summit Series

On March 21-22, 2018 NAMI, the Stanley Center for Psychiatric Research at Broad Institute and the Psychiatric Genomics Consortium hosted the third in a series of Advancing Discovery Summits in Cambridge, Massachusetts. The two-day, invitation-only event convened a diverse group of neuroscience thought leaders from academia and industry, advocacy, government and public policy.

The Advancing Discovery Summit series is a concentrated effort to bring stakeholders from many sectors together to address a very challenging issue. Many medications for mental illnesses have significant side effects ranging from weight gain to movement disorders like tardive dyskinesia – but very few new medications are being developed. NAMI strives to empower our members to advocate for more funding and support for the scientific research that will lead to better therapies. With our partners in brain research, genetic research, pharmaceutical development, and policy – and with your support – we can advance this goal.

​Read a compelling editorial from Dr. Steve Hyman, Director of the Stanley Center for Psychiatric Research.

Read the 2017 Advancing Discovery Summit summary report.

Read the 2018 Advancing Discovery Summit summary report.